News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
WHITNELL JEFFREY A
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/24/2020 |
4
| WHITNELL JEFFREY A (Director) has filed a Form 4 on ELITE PHARMACEUTICALS INC /NV/|
Txns:
| Granted 516,781 shares
@ $0.0871, valued at
$45k
|
|
| 02/27/2018 |
4
| WHITNELL JEFFREY A (Director) has filed a Form 4 on ELITE PHARMACEUTICALS INC /NV/|
Txns:
| Granted 161,374 shares
@ $0.1239, valued at
$20k
|
|
| 02/27/2017 |
4
| WHITNELL JEFFREY A (Director) has filed a Form 4 on ELITE PHARMACEUTICALS INC /NV/|
Txns:
| Granted 88,679 shares
@ $0.2255, valued at
$20k
|
|
| 02/18/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/11/2013 |
4
| WHITNELL JEFFREY A (Director) has filed a Form 4 on ELITE PHARMACEUTICALS INC /NV/|
Txns:
| Granted 184,706 shares
@ $0.08, valued at
$14.8k
Granted 184,706 shares
@ $0.08, valued at
$14.8k
|
|
| 03/21/2012 |
4
| WHITNELL JEFFREY A (Director) has filed a Form 4 on ELITE PHARMACEUTICALS INC /NV/|
Txns:
| Granted 231,633 shares
@ $0.0969, valued at
$22.4k
|
|
| 03/16/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/23/2011 |
3
| WHITNELL JEFFREY A (Director) has filed a Form 3 on ELITE PHARMACEUTICALS INC /DE/ |
| 04/21/2009 |
4
| WHITNELL JEFFREY A (Interim CEO/CFO) has filed a Form 4 on AKORN INC |
|
|